This is a summary of the European public assessment report (EPAR) for Aerius. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Aerius.
Therapeutic Indication
Aerius is indicated for the relief of symptoms associated with: * allergic rhinitis; * urticaria.
Therapeutic Area (MeSH)
ATC Code
R06AX27
ATC Item
N/A
Pharmacotherapeutic Group
Antihistamines for systemic use
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| desloratadine | N/A | desloratadine |
EMA Name
Aerius
Medicine Name
Aerius
Aliases
N/ANo risk management plan link.
